• In late April 2026, FormFactor, Inc. reported first-quarter revenue of US$226.14 million and net income of US$20.38 million, and issued second-quarter guidance calling for revenue around US$240 million and net income per diluted share near US$0.46, alongside expectations for record quarterly revenue and higher margins.
• Management linked this momentum to strong demand for AI-related semiconductor testing and ongoing restructuring and capacity investments, while FormFactor also highlighted its evolving role in advanced test technologies during preparations for its upcoming Nasdaq Closing Bell ceremony.
• Next, we’ll explore how this AI-driven revenue guidance and margin momentum might influence FormFactor’s existing investment narrative and risk profile.

AI is about to change healthcare. These 35 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.

FormFactor Investment Narrative Recap

To own FormFactor today, you really have to believe its probe cards and test systems will remain central to AI and advanced packaging, and that its restructuring and new capacity eventually translate into healthier margins. The latest Q1 beat and Q2 guidance support the near term AI-driven revenue catalyst, while also easing concerns that higher costs and tariffs could drag on profitability; for now, the recent news appears more supportive than disruptive to the existing risk picture.

Among recent developments, management’s Q2 2026 guidance for about US$240 million in revenue and roughly US$0.46 in EPS stands out, because it explicitly ties expected record quarterly revenue and sequential margin gains to AI-related demand. This directly intersects with the key catalyst of accelerating test intensity in HBM and high performance computing, and gives investors a concrete, near term checkpoint to watch as FormFactor ramps its Farmers Branch facility and executes on its restructuring plans.

Yet, against this momentum, investors should also be aware that concentrated DRAM and HBM demand could still swing quarterly results more than many expect...

FormFactor's narrative projects $1.1 billion revenue and $202.2 million earnings by 2029.

Uncover how FormFactor's forecasts yield a $101.56 fair value, a 30% downside to its current price.

Exploring Other Perspectives

Some of the lowest estimate analysts were assuming only about 6.6 percent annual revenue growth to around US$925.3 million by 2028 and earnings near US$91.3 million, which is a much more cautious take than the AI fueled upside implied by recent guidance. Their view highlights how far expectations can differ, and why it is worth comparing this more pessimistic scenario with alternative viewpoints as fresh results and outlook updates come through.

Explore 6 other fair value estimates on FormFactor - why the stock might be worth less than half the current price!

Decide For Yourself

Don't just follow the ticker - dig into the data and build a conviction that's truly your own.

• A great starting point for your FormFactor research is our analysis highlighting 2 key rewards and 2 important warning signs that could impact your investment decision.
• Our free FormFactor research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate FormFactor's overall financial health at a glance.

No Opportunity In FormFactor?

Opportunities like this don't last. These are today's most promising picks. Check them out now:

• Capitalize on the AI infrastructure supercycle with our selection of the 40 best 'picks and shovels' of the AI gold rush converting record-breaking demand into massive cash flow.
• Rare earth metals are the new gold rush. Find out which 33 stocks are leading the charge.
• The future of work is here. Discover the 32 top robotics and automation stocks leading the charge in AI-driven automation and industrial transformation.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.